Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

UC San Diego Medical Center performs complex surgery on brain lesion

Over three decades, a world-recognized medical team at UC San Diego Medical Center has spurred the evolution of a complex surgery to destroy dangerous clusters of arteries and veins in the brain. Integrating innovative approaches in radiology, anesthesia, and surgery, the team has perfected a method to systematically starve these abnormal brain lesions, artery by artery, vein by vein.

17 Dec 2009

INS cites FDA-approved Totect antidote for anthracycline extravasations

The third edition of Infusion Nursing: An Evidence-Based Approach, published by the Infusion Nurses Society (INS), includes Totect(®), the only FDA-approved treatment for anthracycline extravasation. Anthracyclines are a group of chemotherapy medications including daunorubicin, doxorubicin, idarubicin and epirubicin that have been used in the treatment of various types of cancer since the early 1970s.

15 Dec 2009

Revolutions Medical begins mass manufacturing process for safety syringe

Revolutions Medical Corporation ("RevMed" or the "Company"), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it has initiated the mass manufacturing process for the RevVac safety syringe, which is already FDA approved.

14 Dec 2009

Hansen Medical enters into Confidential Settlement Agreement with Luna Innovations

Hansen Medical, Inc. announced today that it has entered into a Confidential Settlement Agreement (the "Settlement Agreement") with Luna Innovations Incorporated (NASDAQ: LUNA) and its wholly-owned subsidiary, Luna Technologies, Inc.

12 Dec 2009

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

LinkMed’s portfolio company Likvor has received an order for Likvor CELDA™ from Uppsala University Hospital (Akademiska Universitetssjukhuset).

11 Dec 2009

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Cell Therapeutics, Inc. announced today an abstract to be published online at the journal Blood website by M. Hacker, et al. demonstrating significant reduction in cardiac cell toxicity with pixantrone compared to currently marketed anthracyclines. The authors conclude that the reduction is due to pixantrone's inability to generate toxic drug iron complexes and reduced propensity to generate oxygen free radicals.

8 Dec 2009

Texas Sinus Center offers FinESS Sinus Treatment to break the cycle of chronic sinusitis

Dr. James Atkins, founder of the Texas Sinus Center (www.texassinuscenter.com), today announced he is now offering the FinESS® Sinus Treatment, a minimally invasive treatment that breaks the cycle of chronic sinusitis (CRS) at Foundation Surgical Hospital of San Antonio.

8 Dec 2009

SAVI applicator for breast brachytherapy can be an effective therapy for breast cancer

The SAVI™ applicator for breast brachytherapy is a safe, effective therapy for breast cancer, according to a newly published study in a peer-reviewed journal.

8 Dec 2009

Geisinger installs catheter-based cardiac assist device, Impella 2.5

A minimally invasive, catheter-based cardiac assist device - the Impella 2.5 - is credited with saving the life of 86-year-old Rose Lombardo of Hazleton. Grandmother to seven and great-grandmother to another 12, Rose was "at death's door" after suffering concurrent heart attacks, according to her daughter, Gabriella Norgard.

8 Dec 2009

Atrium Medical commences enrollment in its INFUSE AMI trial

Atrium Medical Corporation announced that the 1st patient was enrolled in the INFUSE AMI trial. INFUSE AMI is a multi-center, multi-national, prospective, randomized, single blind trial examining how patients with heart attacks are treated. The study's aim is to help determine the best way to treat patients with an acute anterior wall myocardial infarction (acute MI) with ST segment elevation, commonly referred to as STEMIs.

7 Dec 2009

Updated results from phase III EXTEND clinical trial of pixantrone released

Cell Therapeutics, Inc. ("CTI") announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology ("ASH") Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of pixantrone (the "PIX 301 EXTEND trial") in relapsed or refractory, aggressive non-Hodgkin's lymphoma ("NHL") patients who have failed 2 or more prior therapies.

7 Dec 2009

RevMed introduces its proprietary suite of MRI software products at RSNA 2009

Revolutions Medical Corporation ("RevMed" or the "Company"), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it introduced its proprietary suite of MRI software products at this week's Radiology Society of North America (RSNA) annual meeting with great success.

4 Dec 2009

Multi-Lumen MammoSite device to treat breast cancer now available at Jupiter Medical Center

Women fighting breast cancer after a lumpectomy have a new weapon in the battle, now available at Jupiter Medical Center's Foshay Cancer Center. Today, the hospital began treating patients with the Multi-Lumen MammoSite(R) device, just approved in September by the FDA.

4 Dec 2009

New hybrid catheterization table for Toshiba America Medical Systems' five-axis Infinix-i cardiovascular X-ray line

Toshiba America Medical Systems, Inc. has introduced the CAT-880B, a new hybrid catheterization table, for its five-axis InfinixTM-i cardiovascular X-ray line.

2 Dec 2009

nContact Surgical initiates clinical trials of its convergent procedure for paroxysmal AF

nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, today announced the initiation of a feasibility clinical trial designed to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF). This prospective, feasibility study will enroll patients at study sites across the United States.

2 Dec 2009

New data on pixantrone Phase III trial in non-Hodgkin's lymphoma to be presented

Cell Therapeutics, Inc. (CTI) announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present new data on the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL) at the 51st Annual Meeting of the American Society of Hematology on Saturday, December 5, 2009 in New Orleans, Louisiana.

2 Dec 2009

MHI performs its first Amptlazer- Cardiac Plug implant

A multidisciplinary team from the Montreal Heart Institute (MHI), which is affiliated to the Universit- de Montr-al, performed its first catheter implantation of a new prosthesis (Amptlazer- Cardiac Plug) closing the appendage of the left atrium of the heart, which will have the effect of preventing the formation of blood clots and avoiding open-heart surgery.

1 Dec 2009

MHI team performs catheter implantation of the new Amptlazer Cardiac Plug prosthesis

A multidisciplinary team from the Montreal Heart Institute (MHI) performed its first catheter implantation of a new prosthesis (Amptlazer(R) Cardiac Plug) closing the appendage of the left atrium of the heart, which will have the effect of preventing the formation of blood clots and avoiding open-heart surgery. This is excellent news for patients suffering from atrial fibrillation, the most common form of cardiac arrhythmia, affecting at least 5% of Canadians over the age of 70.

30 Nov 2009

University HealthSystem Consortium signs agreement with ECRI Institute

The University HealthSystem Consortium (UHC) today announced that it has signed an agreement with ECRI Institute® in Plymouth Meeting, Pa, to offer its academic medical center members special pricing on ECRI's library of current technology research.

30 Nov 2009

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

At the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from November 29 to December 3 at McCormick Place in Chicago, Siemens Healthcare will introduce its comprehensive portfolio for imaging in interventional oncology at booth #825, East Building/Lakeside Center, Hall D.

30 Nov 2009

Catheter News and Research

Further Reading

UC San Diego Medical Center performs complex surgery on brain lesion

INS cites FDA-approved Totect antidote for anthracycline extravasations

Revolutions Medical begins mass manufacturing process for safety syringe

Hansen Medical enters into Confidential Settlement Agreement with Luna Innovations

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Texas Sinus Center offers FinESS Sinus Treatment to break the cycle of chronic sinusitis

SAVI applicator for breast brachytherapy can be an effective therapy for breast cancer

Geisinger installs catheter-based cardiac assist device, Impella 2.5

Atrium Medical commences enrollment in its INFUSE AMI trial

Updated results from phase III EXTEND clinical trial of pixantrone released

RevMed introduces its proprietary suite of MRI software products at RSNA 2009

Multi-Lumen MammoSite device to treat breast cancer now available at Jupiter Medical Center

New hybrid catheterization table for Toshiba America Medical Systems' five-axis Infinix-i cardiovascular X-ray line

nContact Surgical initiates clinical trials of its convergent procedure for paroxysmal AF

New data on pixantrone Phase III trial in non-Hodgkin's lymphoma to be presented

MHI performs its first Amptlazer- Cardiac Plug implant

MHI team performs catheter implantation of the new Amptlazer Cardiac Plug prosthesis

University HealthSystem Consortium signs agreement with ECRI Institute

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News